Authors
Latest:
Key Takeaways on the Management of Atopic DermatitisPanelists share parting advice and key takeaways on the optimal management of atopic dermatitis within the treatment landscape.
Latest:
Looking at the scalp and nails during a skin exam is keyA presentation from the 2021 virtual American Academy of Pediatrics Conference & Exhibition urges including examination of the scalp and nails during any skin exam.
Latest:
Drug Price Hikes Already Found in 2023List prices of 450 medications have increased 5% overall at the beginning of 2023. More price hikes are expected.
Latest:
Administrative Burden of Prescribing BiologicsPrescribing biologics can require a complex approval and claims process. Creating a tiered system based on office workload can help practices understand and allocate staff time. Outsourcing approvals to pharmacies where possible can also streamline the process.
Latest:
Majority of state medical boards see increase in COVID-19 misinformation complaints against physiciansAn alarming amount of COVID-19 disinformation is prevalent even from physicians.
Latest:
Study: Lifestyle Behaviors Linked With Psoriasis DevelopmentLifestyle behaviors, such as body mass index and smoking, were shown to have a stronger association with psoriasis, regardless of genetic risk.
Latest:
Creating Diverse Teams Takes Work, But Is Worth the EffortOrganizations that focus on diversity, equity and inclusion are more productive and employees are more satisfied.
Latest:
Diverse Perspectives in Medical Aesthetics Matter More Than EverDermatology Times® invites medical professionals in the dermatology community to speak out on the vital issues facing the specialty.
Latest:
How Can AI Improve Patient Care?AI’s ability to quickly process and interpret large quantities of health data is a valuable tool for physicians.
Latest:
Data Support the Use of First-/Second-Line Immune Checkpoint Inhibitors in HNSCCFindings from a retrospective cohort study found that immune checkpoint inhibitors induced promising responses in the first- and second-line treatment of head and neck squamous cell carcinoma.
Latest:
Hedgehog Inhibitor Therapy’s Use in Advanced Basal Cell Carcinoma – Does It Work?A study published in Future Medicine finds consistent use of the treatment is difficult for patients to maintain in a real-world setting.
Latest:
3 Approaches to Creating a Connected Care FutureBy integrating capabilities and services, we can create health experiences that are much more than the sum of their parts.
Latest:
Severe Hemorrhage from Infantile HemangiomaA 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.
Latest:
Take-home Points to Manage AcneDrs Joshua Zeichner, MD, and Mona Gohara, MD, provide take-home messages to providers treating patients with acne.
Latest:
Shingles Vaccination Counseling During the COVID-19 PandemicCDC advises not to delay shingles vaccination.
Latest:
Parents Worries About Severe Acne’s Impact on TeensMore than 90% of respondents to a recent survey expressed concern about acne’s effect on their adolescent’s mental health and social life.
Latest:
Severe Hemorrhage from Infantile HemangiomaA 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.
Latest:
What You Don’t Know and Should Know About PasswordsJ.D. Norcross, director of information technology at VitalSkin Dermatology, discusses some myths and best practices with digital passwords you should know to help keep your practice information safer.
Latest:
FDA Approves Relatlimab Plus Nivolumab for Unresectable or Metastatic MelanomaThe FDA has approved the fixed-dose combination of relatlimab plus nivolumab for the treatment of adult and pediatric patients who are 12 years of age or older and who have unresectable or metastatic melanoma.
Latest:
Impacts of the Inflation Reduction Act on DoctorsHow will new federal law affect lives and wallets of physicians?
Latest:
Biosimilars for Humira Are on Their WayIn 2023 as many as 11 biosimilars to Humira are headed for the US market.
Latest:
Vitiligo: It Is Not Just a Skin ConditionThe melanocytes attacked by the autoimmune disease are present in the eyes and ears, not just the skin, so vitiligo can adversely affect vision and hearing.
Latest:
An Overview of Granulomatous DermatitisGranulomatous dermatitis includes a group of reactive dermatologic disorders characterized by distinct histopathological patterns, clinical manifestations, and associated diseases.
Latest:
A Talk with Albert Yan, MD on Current Trends in TechnologyAt the SPD 2022 47th Annual Meeting, we chat with Albert Yan, MD, of Children's Hospital of Philadelphia on the latest trends in technology for pediatric dermatologists.
Latest:
3 Approaches to Creating a Connected Care FutureBy integrating capabilities and services, we can create health experiences that are much more than the sum of their parts.
Latest:
An Overview of Granulomatous DermatitisGranulomatous dermatitis includes a group of reactive dermatologic disorders characterized by distinct histopathological patterns, clinical manifestations, and associated diseases.
Latest:
How Physicians Can Find the Right AttorneyAs practices grow and become more intimately involved in patients’ complete health care — including regimens of sleep, nutrition, lifestyle, and even wearables — there is more room for lapses, errors or disagreements that pose questions suitable for lawyers.
